Preimplantation Genetic Diagnosis Market Preimplantation Genetic Diagnosis Market : ToC


Preimplantation Genetic Diagnosis Market

Preimplantation Genetic Diagnosis Market (Test Type - PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing and X-linked Diseases) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • Rep Id : TMRGL427
  • Published On : Oct 2014
  • No. of Pages : 84
  • Category : Healthcare

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.4 Research Methodology
1.5 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Preimplantation Genetic Diagnosis Market
2.2 Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Global Preimplantation Genetic Diagnosis Market Overview
3.1 Introduction
     3.1.1 Preimplantation Genetic Diagnosis Process
     3.1.2 Preimplantation Genetic Diagnosis Applications
3.2 Market Dynamics
     3.2.1 Market Drivers
             3.2.1.1 Delay in conception results in increased demand of PGD among higher age women
             3.2.1.2 Increasing incidence rates of genetic diseases influencing patients to undergo PGD cycles for disease free offspring
             3.2.1.3 Lifestyle hazards such as smoking, stress and pollution are leading to decreased fertility resulting in increased demand for IVF and PGD
     3.2.2 Market Restraints
             3.2.2.1 Economic and social factors associated with IVF restrains the PGD market
             3.2.2.2 Limited insurance coverage for IVF and PGD results in less patient pool
     3.2.3 Market Opportunities
             3.2.3.1 Innovation in cancer prevention will increase the demand for PGD during forecast period
             3.2.3.2 Advancement in the field of genetics will propel the growth of PGD market
3.3 Regulatory Framework: Preimplantation Genetic Diagnosis
3.4 Porter’s Five Forces Analysis for the Global Preimplantation Genetic Diagnosis Market
     3.4.1 Bargaining Power of Suppliers
     3.4.2 Bargaining Power of Buyers
     3.4.3 Threat of New Entrants
     3.4.4 Threat of Substitutes
     3.4.5 Competitive Rivalry
3.5 Market Attractiveness Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography
3.6 Competitive Landscape
     3.6.1 Heat Map Analysis for Key Market Players of Global Preimplantation Genetic Diagnosis Market
 
Chapter 4 Global Preimplantation Genetic Diagnosis Market, by Test Type
4.1 Overview
     4.1.1 Global Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
4.2 Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013 & 2020 (Value %)
4.3 PGD for Chromosomal Aberrations
     4.3.1 Global PGD for Chromosomal Aberrations Market Revenue, 2012 – 2020 (USD Million)
4.4 PGD for Aneuploidy Screening
     4.4.1 Global PGD for Aneuploidy Screening Market Revenue, 2012 – 2020 (USD Million)
4.5 PGD for Gender Selection
     4.5.1 Global PGD for Gender Selection Market Revenue, 2012 – 2020 (USD Million)
4.6 PGD for Single Gene Disorder
     4.6.1 Global PGD for Single Gene Disorder Market Revenue, 2012 – 2020 (USD Million)
4.7 PGD for HLA Typing
     4.7.1 Global PGD for HLA Typing Market Revenue, 2012 – 2020 (USD Million)
4.8 PGD for X-linked diseases
     4.8.1 Global PGD for X-linked Diseases Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Preimplantation Genetic Diagnosis Market, by Geography
5.1 Overview
     5.1.1 Global Preimplantation Genetic Diagnosis Market Revenue, by Geography, 2012 – 2020 (USD Million)
5.2 North America
     5.2.1 North America Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
     5.2.2 North America Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
5.3 Europe
     5.3.1 Europe Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
     5.3.2 Europe Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
5.4 Asia Pacific
     5.4.1 Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
     5.4.2 Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
5.5 Rest of the World (RoW)
     5.5.1 Rest of the World Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
     5.5.2 Rest of the World Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
 
Chapter 6 Recommendations
6.1 Introduction of Innovative Technologies to Reduce the Cost of Equipment and Procedure
6.2 Draw from Rapidly Growing CRAMS Market in Emerging Economies
 
Chapter 7 Company Profiles
7.1 Genesis Genetics
     7.1.1 Company Overview
     7.1.2 Financial Overview
     7.1.3 Product Portfolio
     7.1.4 Business Strategies
     7.1.5 Recent Developments
7.2 Genea Ltd.
     7.2.1 Company Overview
     7.2.2 Financial Overview
     7.2.3 Product Portfolio
     7.2.4 Business Strategies
     7.2.5 Recent Developments
7.3 Illumina, Inc.
     7.3.1 Company Overview
     7.3.2 Financial Overview
     7.3.3 Product Portfolio
     7.3.4 Business Strategies
     7.3.5 Recent Developments
7.4 Laboratory Corporation of America Holdings (LabCorp)
     7.4.1 Company Overview
     7.4.2 Financial Overview
     7.4.3 Product Portfolio
     7.4.4 Business Strategies
     7.4.5 Recent Developments
7.5 Natera, Inc.
     7.5.1 Company Overview
     7.5.2 Financial Overview
     7.5.3 Product Portfolio
     7.5.4 Business Strategies
     7.5.5 Recent Developments
7.6 PerkinElmer, Inc.
     7.6.1 Company Overview
     7.6.2 Financial Overview
     7.6.3 Product Portfolio
     7.6.4 Business Strategies
     7.6.5 Recent Developments
7.7 Quest Diagnostics, Inc.
     7.7.1 Company Overview
     7.7.2 Product Portfolio
     7.7.3 Financial Overview
     7.7.4 Business Strategies
     7.7.5 Recent Developments
7.8 Reprogenetics LLC
     7.8.1 Company Overview
     7.8.2 Financial Overview
     7.8.3 Product Portfolio
     7.8.4 Business Strategies
     7.8.5 Recent Developments
7.9 Reproductive Genetics Institute
     7.9.1 Company Overview
     7.9.2 Financial Overview
     7.9.3 Product Portfolio
     7.9.4 Business Strategies
     7.9.5 Recent Developments

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 1 Market Snapshot: Global Preimplantation Genetic Diagnosis Market
TABLE 2 Global Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 3 Global Preimplantation Genetic Diagnosis Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 4 North America Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 5 Europe  Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 6 Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 7 Rest of the World Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)

List of Figures
 
FIG. 1 Preimplantation Genetic Diagnosis Market Segmentation
FIG. 2 Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography, 2013 & 2020 (Value %)
FIG. 4 Preimplantation Genetic Diagnosis Process
FIG. 5 Porter’s Five Forces Analysis for the Global Preimplantation Genetic Diagnosis Market
FIG. 6 Market Attractiveness Analysis of the Global Preimplantation Genetic Diagnosis Market, by Geography
FIG. 7 Heat Map Analysis for Key Market Players of Global Preimplantation Genetic Diagnosis Market
FIG. 8 Comparative Analysis of the Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013 & 2020 (%)
FIG. 9 Global PGD for Chromosomal Aberrations Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global PGD for Aneuploidy Screening Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global PGD for Gender Selection Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global PGD for Single Gene Disorder Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global PGD for HLA Typing Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global PGD for X-linked Diseases Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 North America Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Europe Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Rest of the World Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Illumina, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 20 LabCorp: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 21 PerkinElmer Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Quest Diagnostics: Annual Revenue, 2011 – 2013 (USD Million)